Atrial FibrillationSECAFIB-SURGNCT04090905
Incidence of Post-operative Atrial Fibrillation Secondary to Abdominal Surgery
An observational study of Atrial Fibrillation and Surgery--Complications, run by Frederiksberg University Hospital at 1 site in Denmark.
Trial summary
Background and purpose Post-operative AF (POAF) is considered a phenomenon rather than a definite diagnosis and the current clinical guidelines have no specific recommendations regarding its management. Read more about this study
- Who is it for?
- Ages 16 years and older
- Conditions the study is for
- Atrial Fibrillation, Surgery--Complications
- What is being tested?
- Standard clinical monitoring and Holter monitoring
- How many people
- 466 participants
- Where
- 1 siteDenmark
- Study dates
- 13 Jun 2020to 31 Dec 2021
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 16 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Consecutive adult patients undergoing acute abdominal surgery at the Department of Abdominal Surgery at Bispebjerg Hospital (Copenhagen, Denmark)
Who may be able to join
- Acute abdominal surgery (non-oesophageal)
- Age ≥ 16 years
Who cannot join
- Pregnancy
- Follow-up not possible
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Incidence of Post-operative Atrial Fibrillation Secondary to Abdominal Surgery - A Single-centre, Prospective, Cohort Study
Background and purpose Post-operative AF (POAF) is considered a phenomenon rather than a definite diagnosis and the current clinical guidelines have no specific recommendations regarding its management. Few prospective studies have been performed in non-cardiac conditions and the consequences of POAF in patients without known heart disease are not well described. However, recent data suggest an association between POAF in relation to non-cardiac surgery and increased post-operative mortality and stroke. POAF in relation to abdominal surgery seems common (incidence: 8-18%); however, the true incidence is uncertain. The available studies are few, heterogeneous, and often methodologically inadequate. The study aims at reporting the incidence of atrial fibrillation (AF), and associated complications, in relation to abdominal surgery.
Material and methods Designed as a prospective, single-centre, cohort study of consecutive adult patients undergoing acute* abdominal surgery at the Department of Abdominal Surgery at Bispebjerg Hospital. Patients who are pregnant or where follow-up is not possible will be excluded. Patients will be examined pre-operatively by ECG and signal processed surface ECG (wavECG). A subset of patients admitted to the Department in the time interval of 7 AM to 11 PM$, will be offered heart rhythm monitoring from admission and until discharge (preferably ≥72 hours post-operatively). Additional follow-up will be based on a review of patient charts at discharge and one# month postoperatively. The primary endpoint is the occurrence/recurrence of AF. The study will include 400-500 patients of which an estimated 2/3 will wear heart rhythm monitoring corresponding to 264-330 patients.
Read more
Perspective If more thorough heart rhythm monitoring of patients undergoing abdominal surgery leads to the identification of more patients with AF, routine continuous heart rhythm monitoring should be considered recommended in upcoming guidelines to prevent associated complications.
Footnote(s): See 'Detailed Description' below.
Read the detailed description
Background and rationale Post-operative AF (POAF), i.e. atrial fibrillation (AF) that occurs secondarily to surgery is considered a phenomenon rather than a definite diagnosis, and continuous anti-coagulation is not recommended in AF of short duration and non-persistent AF.1,2 The most recent guidelines from the European and American Societies of Cardiology have no specific recommendation regarding the management of secondary AF, though referral to an outpatient cardiology clinic can be considered if the condition is not self-limiting.3,4 Despite this, recent data from the Framingham population suggest that secondary AF is not a benign condition,5,6 and some studies have found POAF in relation to non-cardiac surgery to be associated with increased post-operative mortality and stroke.7-9 Currently few prospective studies have been performed in non-cardiac conditions and the consequences of secondary AF in patients without known heart disease are not well described. POAF in relation to non-cardiac surgery is common with an average incidence of 10.94%.10 However, the true incidence of POAF in relation to non-cardiac surgery is uncertain, as the available studies are few, heterogeneous, and often methodologically inadequate.10 Different risk-stratification models exist, however it is still challenging to accurately predict which patients will develop AF both perioperatively and in the years following surgery.11-14 Important risk factors for developing POAF are: age (age 65-74, OR 2.08; age >85, OR 3.56), hypertension (OR 3.66), heart failure (OR 1.64), thyroid disease (OR 6.29), laparotomy vs laparoscopy (OR 3.30) and duration of surgery (> 600 min, OR 1.38).10 The use of electrocardiogram (ECG) in risk stratification for AF and stroke is not yet incorporated in clinical guidelines. However, short and prolonged p-wave and p-wave terminal force in lead V1 (PTFV1) is correlated with AF.15 Myovista (HeartSciences, Southlake, Texas, USA) is a novel ECG utilizing continuous wavelet transform signal processing (wavECG) and can be used to prove left ventricular diastolic dysfunction (LVDD).16 LVDD is in other studies associated with AF.17-20 These new biomarkers might improve the identification of patients at risk of developing POAF.
Purpose The study aims at reporting the incidence of AF, and associated complications, in relation to acute abdominal surgery. Concurrently, patients will be characterized by specialized ECG analysis and wavECG.
Methods Prospective, single-centre, cohort study of consecutive patients undergoing acute* abdominal surgery. Patients will be identified among acute referrals for the Department of Abdominal Surgery at Bispebjerg-Frederiksberg Hospital. The Investigator (Department of Cardiology at Bispebjerg-Frederiksberg Hospital) will ensure signed informed consent prior to any study-related examinations. Surgery will be performed at the Department of Abdominal Surgery at Bispebjerg-Frederiksberg Hospital independently of study enrolment. A subset of patients will be enrolled in a feasibility study of continuous cardiac rhythm monitoring (C3+, Cortrium, Copenhagen, Denmark). Heart rhythm monitoring will be worn from admission and until discharge (preferably ≥72 hours post-operatively) in patients admitted to the Department in the time interval of 7 AM to 11 PM$. Additional follow-up will be based on a review of patient charts at discharge and one# month postoperatively.
No randomization or placebo will be used. ECG measurements will be compared to existing data from a healthy population.
Measurements
- ECG: AF, PR-interval, p-wave area, PTFV1
- wavECG: LVDD
- Heart rhythm monitoring: AF
Statistical considerations Consecutive patients attending the Department of Abdominal Surgery at Bispebjerg-Frederiksberg Hospital will be invited to participate in the pre- and post-operative examination programme. The study's aim is to identify the incidence of peri- and postoperative AF. Hence, sample size calculations are uncertain. The expected incidence of AF for patients undergoing non-oesophageal abdominal surgery is at least 7.63%.10 Pre-operative p-wave indices have shown the ability to predict POAF in a cardiac surgery population of 105 patients (with a POAF incidence of 11%).21 wavECG has been used to show LVDD in a study population of 188 patients referred for computed tomography angiography of the heart.16 The study will include 400-500 patients of which an estimated 2/3 will wear heart rhythm monitoring corresponding to 264-330 patients. Follow-up will be one month.
Normality was inspected visually by histograms and tested by Shapiro-Wilk. Nonparametric statistics were used. Wilcoxon rank-sum (continuous variables) and Chi-square and Fisher's exact test (categorical variables) were used as appropriate. Data were presented as median with interquartile range (IQR) for continuous variables and frequency with percentages for categorical variables. Odds ratios (OR) with 95% confidence intervals (CI) were calculated for dichotomous values by univariate logistic regression. Multiple logistic regression was used to adjust for variables' influence on the primary outcome of POAF and the secondary outcome of severe adverse events. Based on an á priori knowledge of risk factors of atrial fibrillation and expected important surgical factors, variables were chosen for the full multivariate model. The following variables were included: age, sex, prior atrial fibrillation, prior stroke, hypertension, heart failure, heart valve disease, chronic renal disease, diabetes mellitus, vascular disease, chronic obstructive pulmonary disease, cancer, surgery invasiveness, and surgery urgency. For multivariate modeling of the secondary outcome, POAF was added to the full model as it was expected to influence the development of the outcome. Subsequently, the full multivariate logistic regression model was reduced to a prediction model. Variables with p<0.05 remained in the prediction model, while variables with p>0.05 were eliminated. Multicollinearity was checked and a Variance Inflation Factor level <5 was accepted. McFadden's R-squared test was applied to evaluate model fit, while Analysis of variance (ANOVA) tests were applied to compare the components of the model, to reduce the risk of overfitting. A receiver operating characteristic curve (ROC) with area under the curve (AUC) was calculated for the multivariate model. The Closest Topleft decision rule was applied to define the optimal sensitivity and specificity values. For AUC, sensitivity, and specificity, 95% confidence intervals were produced through bootstrapping with 2000 replicates. All tests were two-sided, and a p< 0.05 was considered statistically significant. RStudio (version 1.4.1717) was used for statistical analyses.
Footnote(s): *The study was originally designed to include both acute and elective patients, but due to limited availability of heart rhythm monitoring devices, prior to study initiation (June 5, 2020), we decided to enroll patients referred for acute abdominal surgery only. $The study was originally planned to apply heart rhythm monitors all 24 hours of the day. This was not possible due to logistics, and prior to study initiation, we agreed to apply monitoring to all patients admitted between 7 AM to 11 PM. #The study was originally planned for 12 months follow-up but was reduced to one month, due to limitations of the permissions achieved prior to study initiation. In addition, an outpatient clinic visit 3 months after surgery was planned where ECG and heart rhythm monitor examinations were to be repeated. The visits were canceled due to local COVID-19 restrictions.
- Conditions
- Atrial Fibrillation, Surgery--Complications
- Being tested
- Standard clinical monitoring, Holter monitoring
- Keywords
- post-operative atrial fibrillation, abdominal surgery
- Medical subject headings
- Atrial Fibrillation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Standard clinical monitoringOther
Standard observation in either a surgical ward (utilizing the National Early Warning Score) or the intensive care unit with continuous respiratory and circulatory monitoring.
Holter monitoringDiagnostic test
Cardiac rhythm monitoring before, during, and until hospital discharge (preferably ≥72 hours after abdominal surgery)
| Study group | Role | What they receive |
|---|---|---|
| Unselected cohort | Consecutive adult patients who were referred for acute abdominal surgery. Patients underwent standard observation in either a surgical ward (utilizing the National Early Warning Score) or the intensive care unit with continuous respiratory and circulatory monitoring. Receives: Other: Standard clinical monitoring | |
| Subgroup with Holter monitoring | Consecutive adult patients who were referred for acute abdominal surgery in the time interval 7 AM to 11 PM. Holter monitoring was applied on top of standard observation in either a surgical ward (utilizing the National Early Warning Score) or the intensive care unit with continuous respiratory and circulatory monitoring. Receives: Other: Standard clinical monitoring; Diagnostic Test: Holter monitoring |
What is being measured
The primary outcome is the main question the study is designed to answer.
Incidence of clinically recognized peri- and post-operative atrial fibrillation
Occurrence of clinically recognized POAF, defined as recognized by clinical staff and verified by a 12-lead electrocardiogram and adjudicated by Cardiology specialists.
Measured: In-hospital, defined as occurring from termination of surgery and until discharge from the hospital. Assessed up to 7 days from surgery.
Secondary outcomes (6)
Incidence of peri- and post-operative atrial fibrillation by cardiac rhythm monitoring
Atrial fibrillation (AF) lasting more than 30 seconds on cardiac rhythm monitoring was sufficient for an AF diagnosis.
Measured: In-hospital, defined as occurring from termination of surgery and until discharge from the hospital. Assessed up to 7 days from surgery.
Incidence of clinically recognized post-operative atrial fibrillation
Occurrence of clinically recognized POAF, defined as recognized by clinical staff and verified by a 12-lead electrocardiogram and adjudicated by Cardiology specialists.
Measured: Out-of-hospital, defined as within 30 days from index surgery
Incidence of clinical events after surgery
Clinical events defined as: death, life-threatening complications, major abdominal reoperation, prolonged hospitalization (admissions with complications requiring hospitalization beyond standard treatment)
Measured: In-hospital, defined as occurring from termination of surgery and until discharge from the hospital. Assessed up to 7 days from surgery.
Incidence of clinical events after surgery
Clinical events defined as: death, life-threatening complications, major abdominal reoperation, prolonged hospitalization (admissions with complications requiring hospitalization beyond standard treatment), or hospital readmission.
Measured: Out-of-hospital, defined as within 30 days from index surgery
Number of patients with abnormal p-wave indexes
Abnormal p-wave indexes on electrocardiogram
Measured: Before surgery
Number of patients with left ventricular diastolic dysfunction
Left ventricular diastolic dysfunction as measured on wavECG (Myovista)
Measured: Before surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Sep 2019
- Study start13 Jun 2020
- Primary completion1 Oct 2021
- Study completion31 Dec 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Atrial FibrillationStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 466 participants (actual)
Sponsor and investigators
- Lead sponsor
- Frederiksberg University Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Christoffer Valdorff Madsen, Frederiksberg University Hospital
- Investigators
- Christoffer V Madsen, MD, Principal investigator, University Hospital Bispebjerg and Frederiksberg
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04090905
- Sponsor's protocol ID
- H-19033464
- Acronym
- SECAFIB-SURG
- Status last verified
- May 2022
- First submitted
- 13 Sep 2019
- Last updated
- 27 May 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 27 May 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Incidence of Post-operative Atrial Fibrillation Secondary to Abdominal Surgery - A Single-centre, Prospective, Cohort Study
- ClinicalTrials.gov ID
- NCT04090905
- Acronym / sponsor ID
- SECAFIB-SURG / H-19033464
- Conditions
- Atrial Fibrillation, Surgery--Complications
- Keywords
- post-operative atrial fibrillation, abdominal surgery
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 466 participants (actual)
- Lead sponsor
- Frederiksberg University HospitalUniversity, hospital or other
- Study start
- 13 Jun 2020 (actual)
- Primary completion
- 1 Oct 2021 (actual)
- Study completion
- 31 Dec 2021 (actual)
- First posted
- 16 Sep 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Background and purpose Post-operative AF (POAF) is considered a phenomenon rather than a definite diagnosis and the current clinical guidelines have no specific recommendations regarding its management. Few prospective studies have been performed in non-cardiac conditions and the consequences of POAF in patients without known heart disease are not well described. However, recent data suggest an association between POAF in relation to non-cardiac surgery and increased post-operative mortality and stroke. POAF in relation to abdominal surgery seems common (incidence: 8-18%); however, the true incidence is uncertain. The available studies are few, heterogeneous, and often methodologically inadequate. The study aims at reporting the incidence of atrial fibrillation (AF), and associated complications, in relation to abdominal surgery.
Material and methods Designed as a prospective, single-centre, cohort study of consecutive adult patients undergoing acute* abdominal surgery at the Department of Abdominal Surgery at Bispebjerg Hospital. Patients who are pregnant or where follow-up is not possible will be excluded. Patients will be examined pre-operatively by ECG and signal processed surface ECG (wavECG). A subset of patients admitted to the Department in the time interval of 7 AM to 11 PM$, will be offered heart rhythm monitoring from admission and until discharge (preferably ≥72 hours post-operatively). Additional follow-up will be based on a review of patient charts at discharge and one# month postoperatively. The primary endpoint is the occurrence/recurrence of AF. The study will include 400-500 patients of which an estimated 2/3 will wear heart rhythm monitoring corresponding to 264-330 patients.
Perspective If more thorough heart rhythm monitoring of patients undergoing abdominal surgery leads to the identification of more patients with AF, routine continuous heart rhythm monitoring should be considered recommended in upcoming guidelines to prevent associated complications.
Footnote(s): See 'Detailed Description' below.
Detailed description
Background and rationale Post-operative AF (POAF), i.e. atrial fibrillation (AF) that occurs secondarily to surgery is considered a phenomenon rather than a definite diagnosis, and continuous anti-coagulation is not recommended in AF of short duration and non-persistent AF.1,2 The most recent guidelines from the European and American Societies of Cardiology have no specific recommendation regarding the management of secondary AF, though referral to an outpatient cardiology clinic can be considered if the condition is not self-limiting.3,4 Despite this, recent data from the Framingham population suggest that secondary AF is not a benign condition,5,6 and some studies have found POAF in relation to non-cardiac surgery to be associated with increased post-operative mortality and stroke.7-9 Currently few prospective studies have been performed in non-cardiac conditions and the consequences of secondary AF in patients without known heart disease are not well described. POAF in relation to non-cardiac surgery is common with an average incidence of 10.94%.10 However, the true incidence of POAF in relation to non-cardiac surgery is uncertain, as the available studies are few, heterogeneous, and often methodologically inadequate.10 Different risk-stratification models exist, however it is still challenging to accurately predict which patients will develop AF both perioperatively and in the years following surgery.11-14 Important risk factors for developing POAF are: age (age 65-74, OR 2.08; age >85, OR 3.56), hypertension (OR 3.66), heart failure (OR 1.64), thyroid disease (OR 6.29), laparotomy vs laparoscopy (OR 3.30) and duration of surgery (> 600 min, OR 1.38).10 The use of electrocardiogram (ECG) in risk stratification for AF and stroke is not yet incorporated in clinical guidelines. However, short and prolonged p-wave and p-wave terminal force in lead V1 (PTFV1) is correlated with AF.15 Myovista (HeartSciences, Southlake, Texas, USA) is a novel ECG utilizing continuous wavelet transform signal processing (wavECG) and can be used to prove left ventricular diastolic dysfunction (LVDD).16 LVDD is in other studies associated with AF.17-20 These new biomarkers might improve the identification of patients at risk of developing POAF.
Purpose The study aims at reporting the incidence of AF, and associated complications, in relation to acute abdominal surgery. Concurrently, patients will be characterized by specialized ECG analysis and wavECG.
Methods Prospective, single-centre, cohort study of consecutive patients undergoing acute* abdominal surgery. Patients will be identified among acute referrals for the Department of Abdominal Surgery at Bispebjerg-Frederiksberg Hospital. The Investigator (Department of Cardiology at Bispebjerg-Frederiksberg Hospital) will ensure signed informed consent prior to any study-related examinations. Surgery will be performed at the Department of Abdominal Surgery at Bispebjerg-Frederiksberg Hospital independently of study enrolment. A subset of patients will be enrolled in a feasibility study of continuous cardiac rhythm monitoring (C3+, Cortrium, Copenhagen, Denmark). Heart rhythm monitoring will be worn from admission and until discharge (preferably ≥72 hours post-operatively) in patients admitted to the Department in the time interval of 7 AM to 11 PM$. Additional follow-up will be based on a review of patient charts at discharge and one# month postoperatively.
No randomization or placebo will be used. ECG measurements will be compared to existing data from a healthy population.
Measurements
- ECG: AF, PR-interval, p-wave area, PTFV1
- wavECG: LVDD
- Heart rhythm monitoring: AF
Statistical considerations Consecutive patients attending the Department of Abdominal Surgery at Bispebjerg-Frederiksberg Hospital will be invited to participate in the pre- and post-operative examination programme. The study's aim is to identify the incidence of peri- and postoperative AF. Hence, sample size calculations are uncertain. The expected incidence of AF for patients undergoing non-oesophageal abdominal surgery is at least 7.63%.10 Pre-operative p-wave indices have shown the ability to predict POAF in a cardiac surgery population of 105 patients (with a POAF incidence of 11%).21 wavECG has been used to show LVDD in a study population of 188 patients referred for computed tomography angiography of the heart.16 The study will include 400-500 patients of which an estimated 2/3 will wear heart rhythm monitoring corresponding to 264-330 patients. Follow-up will be one month.
Normality was inspected visually by histograms and tested by Shapiro-Wilk. Nonparametric statistics were used. Wilcoxon rank-sum (continuous variables) and Chi-square and Fisher's exact test (categorical variables) were used as appropriate. Data were presented as median with interquartile range (IQR) for continuous variables and frequency with percentages for categorical variables. Odds ratios (OR) with 95% confidence intervals (CI) were calculated for dichotomous values by univariate logistic regression. Multiple logistic regression was used to adjust for variables' influence on the primary outcome of POAF and the secondary outcome of severe adverse events. Based on an á priori knowledge of risk factors of atrial fibrillation and expected important surgical factors, variables were chosen for the full multivariate model. The following variables were included: age, sex, prior atrial fibrillation, prior stroke, hypertension, heart failure, heart valve disease, chronic renal disease, diabetes mellitus, vascular disease, chronic obstructive pulmonary disease, cancer, surgery invasiveness, and surgery urgency. For multivariate modeling of the secondary outcome, POAF was added to the full model as it was expected to influence the development of the outcome. Subsequently, the full multivariate logistic regression model was reduced to a prediction model. Variables with p<0.05 remained in the prediction model, while variables with p>0.05 were eliminated. Multicollinearity was checked and a Variance Inflation Factor level <5 was accepted. McFadden's R-squared test was applied to evaluate model fit, while Analysis of variance (ANOVA) tests were applied to compare the components of the model, to reduce the risk of overfitting. A receiver operating characteristic curve (ROC) with area under the curve (AUC) was calculated for the multivariate model. The Closest Topleft decision rule was applied to define the optimal sensitivity and specificity values. For AUC, sensitivity, and specificity, 95% confidence intervals were produced through bootstrapping with 2000 replicates. All tests were two-sided, and a p< 0.05 was considered statistically significant. RStudio (version 1.4.1717) was used for statistical analyses.
Footnote(s): *The study was originally designed to include both acute and elective patients, but due to limited availability of heart rhythm monitoring devices, prior to study initiation (June 5, 2020), we decided to enroll patients referred for acute abdominal surgery only. $The study was originally planned to apply heart rhythm monitors all 24 hours of the day. This was not possible due to logistics, and prior to study initiation, we agreed to apply monitoring to all patients admitted between 7 AM to 11 PM. #The study was originally planned for 12 months follow-up but was reduced to one month, due to limitations of the permissions achieved prior to study initiation. In addition, an outpatient clinic visit 3 months after surgery was planned where ECG and heart rhythm monitor examinations were to be repeated. The visits were canceled due to local COVID-19 restrictions.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Unselected cohort | – | Other: Standard clinical monitoringConsecutive adult patients who were referred for acute abdominal surgery. Patients underwent standard observation in either a surgical ward (utilizing the National Early Warning Score) or the intensive care unit with continuous respiratory and circulatory monitoring. |
| Subgroup with Holter monitoring | – | Other: Standard clinical monitoring, Diagnostic Test: Holter monitoringConsecutive adult patients who were referred for acute abdominal surgery in the time interval 7 AM to 11 PM. Holter monitoring was applied on top of standard observation in either a surgical ward (utilizing the National Early Warning Score) or the intensive care unit with continuous respiratory and circulatory monitoring. |
Who may qualify
- Ages
- 16 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Consecutive adult patients undergoing acute abdominal surgery at the Department of Abdominal Surgery at Bispebjerg Hospital (Copenhagen, Denmark)
Key inclusion criteria (2 listed)
- Acute abdominal surgery (non-oesophageal)
- Age ≥ 16 years
Key exclusion criteria (2 listed)
- Pregnancy
- Follow-up not possible
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Standard clinical monitoringStandard observation in either a surgical ward (utilizing the National Early Warning Score) or the intensive care unit with continuous respiratory and circulatory monitoring. | Other | Subgroup with Holter monitoring, Unselected cohort |
| Holter monitoringCardiac rhythm monitoring before, during, and until hospital discharge (preferably ≥72 hours after abdominal surgery) | Diagnostic test | Subgroup with Holter monitoring |
Primary outcome
Incidence of clinically recognized peri- and post-operative atrial fibrillation
Time frame: In-hospital, defined as occurring from termination of surgery and until discharge from the hospital. Assessed up to 7 days from surgery.
Occurrence of clinically recognized POAF, defined as recognized by clinical staff and verified by a 12-lead electrocardiogram and adjudicated by Cardiology specialists.
6 secondary outcomes
Incidence of peri- and post-operative atrial fibrillation by cardiac rhythm monitoring
Time frame: In-hospital, defined as occurring from termination of surgery and until discharge from the hospital. Assessed up to 7 days from surgery.
Incidence of clinically recognized post-operative atrial fibrillation
Time frame: Out-of-hospital, defined as within 30 days from index surgery
Incidence of clinical events after surgery
Time frame: In-hospital, defined as occurring from termination of surgery and until discharge from the hospital. Assessed up to 7 days from surgery.
Incidence of clinical events after surgery
Time frame: Out-of-hospital, defined as within 30 days from index surgery
Number of patients with abnormal p-wave indexes
Time frame: Before surgery
Number of patients with left ventricular diastolic dysfunction
Time frame: Before surgery
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 27 May 2022.
- Individual participant dataSharing planned: Undecided
Related trials for Atrial Fibrillation
Active, not recruiting
Horizon 360 Protocol for the Treatment of Paroxysmal Atrial Fibrillation With the Sphere-360™ Catheter and Affera™ Mapping and Ablation System (Horizon 360)
Paroxysmal AF
Active, not recruitingObservational study
Concomitant Left Atrial Appendage Closure and Pulsed Field Ablation-Asia
Concomitant Procedures, Atrial Fibrillation
Active, not recruiting
CONVERGE Post-Approval Study (PAS)
Chronic Atrial Fibrillation
Recruiting
Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy
Ischemic Stroke, Atrial Fibrillation
RecruitingPhase 2
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Atrial Fibrillation (AF)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Christoffer V Madsen, MD principal investigator
University Hospital Bispebjerg and Frederiksberg
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Atrial Fibrillation and Surgery--Complications, run by Frederiksberg University Hospital at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 27 May 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Incidence of clinically recognized peri- and post-operative atrial fibrillation (time frame: In-hospital, defined as occurring from termination of surgery and until discharge from the hospital. Assessed up to 7 days from surgery.). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 May 2022.